SG11201408053TA - Mixture for the inhibition of melanin biosynthesis - Google Patents

Mixture for the inhibition of melanin biosynthesis

Info

Publication number
SG11201408053TA
SG11201408053TA SG11201408053TA SG11201408053TA SG11201408053TA SG 11201408053T A SG11201408053T A SG 11201408053TA SG 11201408053T A SG11201408053T A SG 11201408053TA SG 11201408053T A SG11201408053T A SG 11201408053TA SG 11201408053T A SG11201408053T A SG 11201408053TA
Authority
SG
Singapore
Prior art keywords
mixture
skin
inhibition
melanin biosynthesis
cosmetic
Prior art date
Application number
SG11201408053TA
Inventor
Paoli Ambrosi Gianfranco De
Original Assignee
Gen Topics Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Topics Srl filed Critical Gen Topics Srl
Publication of SG11201408053TA publication Critical patent/SG11201408053TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

MIXTURE FOR THE INHIBITION OF MELANIN BIOSYNTHESIS The present invention relates to a mixture comprising acetylglucosamine and 4-(l-phenylethyl)-l,3-benzenediol for use as a cosmetic and/or medicament, and par­ ticularly for the inhibition of melanin biosynthesis, and to a cosmetic and/or pharma- 5 ceutical formulation comprising such mixture a for the treatment of hyperpigmented lesions of the skin such as, for example but without limitation, lentigo solaris, age spots, melasma and chloasma, for rendering uniform the color of the skin, for counter­ acting the formation of free radicals, and for counteracting or preventing signs of skin aging such as wrinkles and lack of skin tone, and generally for improving the aesthet- 10 ic conditions of the skin. No illustrative drawing.
SG11201408053TA 2012-06-04 2013-06-04 Mixture for the inhibition of melanin biosynthesis SG11201408053TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000092A ITBS20120092A1 (en) 2012-06-04 2012-06-04 MIXTURE FOR THE INHIBITION OF MELANIN BIOSYNTHESIS
PCT/IB2013/054606 WO2013182996A1 (en) 2012-06-04 2013-06-04 Mixture for the inhibition of melanin biosynthesis

Publications (1)

Publication Number Publication Date
SG11201408053TA true SG11201408053TA (en) 2015-01-29

Family

ID=46758827

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201408053TA SG11201408053TA (en) 2012-06-04 2013-06-04 Mixture for the inhibition of melanin biosynthesis
SG10201704303VA SG10201704303VA (en) 2012-06-04 2013-06-04 Mixture for the inhibition of melanin biosynthesis

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201704303VA SG10201704303VA (en) 2012-06-04 2013-06-04 Mixture for the inhibition of melanin biosynthesis

Country Status (14)

Country Link
US (1) US20150110725A1 (en)
EP (1) EP2854783B1 (en)
JP (1) JP2015518877A (en)
KR (1) KR20150023544A (en)
CN (1) CN104507462A (en)
EA (1) EA030102B1 (en)
ES (1) ES2668848T3 (en)
IN (1) IN2014MN02468A (en)
IT (1) ITBS20120092A1 (en)
MY (1) MY169101A (en)
PL (1) PL2854783T3 (en)
SG (2) SG11201408053TA (en)
TR (1) TR201806726T4 (en)
WO (1) WO2013182996A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11071701B2 (en) 2016-06-30 2021-07-27 Symrise Ag Medicament and cosmetic composition comprising resorcinol derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002053448A (en) * 2000-07-28 2002-02-19 Pentapharm Ltd Outdoor cosmetic
DE10324566A1 (en) * 2003-05-30 2004-12-16 Symrise Gmbh & Co. Kg Use of diphenylmethane derivatives as tyrosinase inhibitors
US20090162305A1 (en) 2006-01-05 2009-06-25 Symrise Gmbh & Co. Kg Formulations of low oil content comprising diphenylmethane derivatives
CN101139288B (en) * 2006-09-07 2011-06-15 黑龙江大学 Method for preparating ethyl linoleate by catalysis of composite solid ultra-strong acid
KR101362619B1 (en) * 2008-02-20 2014-02-13 이엘씨 매니지먼트 엘엘씨 Topical compositions and methods for whitening skin
FR2939669B1 (en) * 2008-12-17 2011-03-25 Oreal COSMETIC METHOD FOR CONTROLLING SKIN BLIND INDUCED BY UV RADIATION; Compositions.
SG10202009963PA (en) * 2011-01-07 2020-11-27 Allergan Inc Melanin modification compositions and methods of use

Also Published As

Publication number Publication date
IN2014MN02468A (en) 2015-07-10
ITBS20120092A1 (en) 2013-12-05
EA201492153A1 (en) 2015-05-29
WO2013182996A1 (en) 2013-12-12
ES2668848T3 (en) 2018-05-22
TR201806726T4 (en) 2018-06-21
JP2015518877A (en) 2015-07-06
SG10201704303VA (en) 2017-07-28
US20150110725A1 (en) 2015-04-23
PL2854783T3 (en) 2018-08-31
EA030102B1 (en) 2018-06-29
MY169101A (en) 2019-02-18
EP2854783B1 (en) 2018-02-14
EP2854783A1 (en) 2015-04-08
KR20150023544A (en) 2015-03-05
CN104507462A (en) 2015-04-08

Similar Documents

Publication Publication Date Title
WO2010083368A3 (en) Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions
PH12015501806A1 (en) Novel benzopyran kinase modulators
WO2012108689A3 (en) Novel compound having skin-whitening, anti-oxidizing and ppar activities and medical use therefor
MX366774B (en) Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1.
MX339820B (en) Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1.
EP2193785A3 (en) Extracts of Tetraselmis sp. for cosmetic and therapeutic purposes
MX352412B (en) Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo.
BR112013002216A2 (en) "use of roasted coffee beans to regulate skin pigmentation"
MX2019008063A (en) 17a,21-diesters of cortexolone for use in the treatment of tumors.
BR112012032877A2 (en) use of chicoric acid and derivatives for skin pigmentation regulation
WO2012108677A3 (en) Novel compound having skin-whitening, anti-oxidizing and ppar activities and medical use therefor
Kuo et al. In vitro and in vivo studies on protective action of N-phenethyl caffeamide against photodamage of skin
WO2011121250A3 (en) Cosmetic and pharmaceutical composition comprising n-acetylglucosamine-6-phosphate
IN2014DN08921A (en)
WO2011034962A3 (en) Compounds that modulate intracellular calcium
CA2899814A1 (en) Methods of skin whitening by use of canola extracts
Ng et al. Anti-melanogenic effects of δ-tocotrienol are associated with tyrosinase-related proteins and MAPK signaling pathway in B16 melanoma cells
MX2015008783A (en) Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one specific amide compound.
MY161419A (en) Skin collagen production-promoting agent
MX345695B (en) Heterocyclocarbonylaminothiazoles, cosmetic or dermatological preparations containing said heterocyclocarbonylaminothiazoles, and use thereof to combat or prevent undesired pigmentation of the skin.
PH12017501200A1 (en) A skin lightening composition comprising niacinamide and ilomastat
MX2015009054A (en) Cosmetic or dermatological composition comprising a merocyanine, an oily phase and a c1-c4 monoalkanol.
SG11201408053TA (en) Mixture for the inhibition of melanin biosynthesis
WO2018150395A4 (en) 4-n-butylresorcinol preparations
TN2011000554A1 (en) Use of delta-tocopheryl-carbohydrate as a depigmenting agent